D'Arrigo C - Search Results

1

Short- and long-term effects on prolactin of risperidone and olanzapine treatments in children and adolescents.

Migliardi G, Spina E, D'Arrigo C, Gagliano A, Germanò E, Siracusano R, Diaz FJ, de Leon J. Migliardi G, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1496-501. doi: 10.1016/j.pnpbp.2009.08.009. Epub 2009 Aug 23. Prog Neuropsychopharmacol Biol Psychiatry. 2009. PMID: 19706318 Clinical Trial.

2

Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder.

D'Amico G, Cedro C, Muscatello MR, Pandolfo G, Di Rosa AE, Zoccali R, La Torre D, D'Arrigo C, Spina E. D'Amico G, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Jun;27(4):619-23. doi: 10.1016/S0278-5846(03)00050-2. Prog Neuropsychopharmacol Biol Psychiatry. 2003. PMID: 12787848 Clinical Trial.

3

Plasma risperidone concentrations during combined treatment with sertraline.

Spina E, D'Arrigo C, Migliardi G, Morgante L, Zoccali R, Ancione M, Madia A. Spina E, et al. Ther Drug Monit. 2004 Aug;26(4):386-90. doi: 10.1097/00007691-200408000-00008. Ther Drug Monit. 2004. PMID: 15257068 Clinical Trial.

4

Plasma concentrations of risperidone and olanzapine during coadministration with oxcarbazepine.

Rosaria Muscatello M, Pacetti M, Cacciola M, La Torre D, Zoccali R, D'Arrigo C, Migliardi G, Spina E. Rosaria Muscatello M, et al. Epilepsia. 2005 May;46(5):771-4. doi: 10.1111/j.1528-1167.2005.71104.x. Epilepsia. 2005. PMID: 15857446 Free article.

5

Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophrenia.

D'Arrigo C, Migliardi G, Santoro V, Morgante L, Muscatello MR, Ancione M, Spina E. D'Arrigo C, et al. Pharmacol Res. 2005 Dec;52(6):497-501. doi: 10.1016/j.phrs.2005.09.005. Epub 2005 Oct 11. Pharmacol Res. 2005. PMID: 16226034

6

Determination of olanzapine in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection.

D'Arrigo C, Migliardi G, Santoro V, Spina E. D'Arrigo C, et al. Ther Drug Monit. 2006 Jun;28(3):388-93. doi: 10.1097/01.ftd.0000211800.66569.c9. Ther Drug Monit. 2006. PMID: 16778724

7

Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder.

Spina E, D'Arrigo C, Migliardi G, Santoro V, Muscatello MR, Micò U, D'Amico G, Perucca E. Spina E, et al. Ther Drug Monit. 2006 Oct;28(5):599-602. doi: 10.1097/01.ftd.0000246763.59506.b0. Ther Drug Monit. 2006. PMID: 17038872 Clinical Trial.

8

Effect of topiramate on plasma concentrations of clozapine, olanzapine, risperidone, and quetiapine in patients with psychotic disorders.

Migliardi G, D'Arrigo C, Santoro V, Bruno A, Cortese L, Campolo D, Cacciola M, Spina E. Migliardi G, et al. Clin Neuropharmacol. 2007 Mar-Apr;30(2):107-13. doi: 10.1097/01.wnf.0000240955.49315.65. Clin Neuropharmacol. 2007. PMID: 17414943 Clinical Trial.

9

Effect of valproate on olanzapine plasma concentrations in patients with bipolar or schizoaffective disorder.

Spina E, D'Arrigo C, Santoro V, Muscatello MR, Pandolfo G, Zoccali R, Diaz FJ, de Leon J. Spina E, et al. Ther Drug Monit. 2009 Dec;31(6):758-63. doi: 10.1097/FTD.0b013e3181c0590e. Ther Drug Monit. 2009. PMID: 19865002

10

Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia.

Zoccali R, Muscatello MR, Torre DL, Malara G, Canale A, Crucitti D, D'Arrigo C, Spina E. Zoccali R, et al. Pharmacol Res. 2003 Oct;48(4):411-4. doi: 10.1016/s1043-6618(03)00178-6. Pharmacol Res. 2003. PMID: 12902213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters